BMJ 2005;331 (1 October), doi:10.1136/bmj.331.7519.0
Misoprostol helps anaemic women in childbirth
Routine use of misoprostol as a sublingual tablet may reduce postpartum morbidity and mortality in developing countries, where many pregnant women are anaemic. In a randomised double blind placebo controlled trial of 661 women in Guinea-Bissau, Høj and colleagues (p 723) found that 600 µg misoprostol significantly reduced the incidence of severe postpartum haemorrhage. Compared with women randomised to placebo, women who received the drug lost less blood and had a smaller decrease in haemoglobin concentration.
|
|
Credit: CHRIS SATTLBERGER/PANOS
|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Related Article
- Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial
- Lars Høj, Placido Cardoso, Birgitte Bruun Nielsen, Lone Hvidman, Jens Nielsen, and Peter Aaby
BMJ 2005 331: 723.[Abstract] [Full Text] [PDF]
This article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related content
Bookmark with
What's new
BMJ video
Resources
Tools
Online poll
Find out more
Services
Rapid responses for this article
There are no rapid responses for this article.Most read last week
Print issues
Student BMJ
Risk of surgery for inflammatory bowel disease: record linkage studies
What can you learn from this BMJ paper? Read Leanne Tite's Paper+
